Market revenue in 2023 | USD 173.7 million |
Market revenue in 2030 | USD 332.1 million |
Growth rate | 9.7% (CAGR from 2023 to 2030) |
Largest segment | Blood sample |
Fastest growing segment | Blood Sample |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Blood Sample |
Key market players worldwide | ANGLE PLC, Guardant Health Inc, Myriad Genetics Inc, Biocept Inc, Lucence Health, Roche, Qiagen NV, Illumina Inc, Thermo Fisher Scientific Inc, Epigenomics AG, Oncimmune, Freenome |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to liquid biopsy market will help companies and investors design strategic landscapes.
Blood sample was the largest segment with a revenue share of 73.34% in 2023. Horizon Databook has segmented the Middle East & Africa liquid biopsy market based on blood sample covering the revenue growth of each sub-segment from 2018 to 2030.
Middle East and Africa is one of the regions with tremendous growth opportunity, as majority of the market is untapped due to unavailability of organized cancer screening programs in this region, especially in underdeveloped African countries.
In recent years, countries such as the UAE, Morocco, & South Africa have implemented organized cancer screening programs. Collaborations of various companies with government institutes to supply these tests are also expected to boost the market.
These initiatives are anticipated to lead to development of newer liquid biopsy tests. Liquid biopsy tests are expensive and new. Thus, there is a shortage of experienced professionals to perform these tests. Furthermore, lack of political support and necessary resources may restrain market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa liquid biopsy market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa liquid biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account